A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

Individual plans that are compliant with the Affordable Care Act and are purchased on Healthcare.gov or through a local agent in North Dakota include coverage for glucagon-like peptide-1 (GLP-1 ...

There are more than 300 GLP-1Rs in an active stage of development, from industry giants and potential market disrupters.

On Jan. 1, North Dakota became the first state in the country where access to drugs like Wegovy is part of the EHB package. About 55,293 of North Dakota's 784,000 residents had coverage through fully ...

Discover how North Dakota is leading the way by covering Ozempic for weight loss under ACA plans, making it the first U.S. state to take this step.

August 15, 2024, Paper: "Glucagon-like peptide 1 (GLP-1) receptor agonists and dual GLP-1/gastric inhibitory polypeptide (GIP) receptor agonists are among the most promising medical innovations of the ...

Advert As for their active substance, Mounjaro contains tirzepatide, which is a gastric inhibitory polypeptide analog and GLP-1 receptor agonist. Ozempic contains a peptide similar to the hormone ...

The development of glucagon-like peptide-1 (GLP-1) drugs — which have a range of beneficial ... Zepbound also enhances levels of GIP (gastric inhibitory polypeptide), another hormone that the body ...

Osteoarthritis (OA) is a common progressive degenerative disease. Gut microbiota (GM) and their metabolites have been closely associated with the onset, progression, and pathology of OA. GM and their ...

Sun Pharmaceutical Industries Ltd. has divulged incretin analogues acting as dual agonists of gastric inhibitory polypeptide (GIPR) receptor/GLP-1 or GLP-1/glucagon receptor (GCGR) or triple agonists ...